Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ESCA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 2,000 | $21.00 | $42.0K Sale | Form 4 ↗ |
| Aug 13, 2026 | Edward E. Williams Director | ESCA Escalade, Incorporated | Sale | 2,373 | $20.99 | $49.8K Sale | Form 4 ↗ |
| Aug 12, 2026 | Edward E. Williams Director | ESCA Escalade, Incorporated | Sale | 362 | $20.96 | $7,588 Sale | Form 4 ↗ |
| Aug 11, 2026 | Edward E. Williams Director | ESCA Escalade, Incorporated | Sale | 30,315 | $20.98 | $636.0K Sale | Form 4 ↗ |
| Aug 6, 2026 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 5,000 | $22.27 | $111.3K Sale | Form 4 ↗ |
| Aug 4, 2026 | Walter P. Glazer Jr. Director | ESCA Escalade, Incorporated | Sale | 16,374 | $21.08 | $345.2K Sale | Form 4 ↗ |
| Aug 4, 2026 | Stephen Wawrin CHIEF FINANCIAL OFFICER | ESCA Escalade, Incorporated | Sale | 3,177 | $21.40 | $68.0K Sale | Form 4 ↗ |
| May 8, 2026 | Walter P. Glazer Jr. Director | ESCA Escalade, Incorporated | Sale | 1,048 | $19.80 | $20.8K Sale | Form 4 ↗ |
| May 7, 2026 | Walter P. Glazer Jr. Director | ESCA Escalade, Incorporated | Sale | 32,578 | $19.83 | $646.0K Sale | Form 4 ↗ |
| Dec 11, 2025 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 5,490 | $13.00 | $71.4K Sale | Form 4 ↗ |
| Dec 10, 2025 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 4,224 | $13.00 | $54.9K Sale | Form 4 ↗ |
| Dec 1, 2025 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 286 | $13.35 | $3,818 Sale | Form 4 ↗ |
| Nov 21, 2025 | Stephen Wawrin CHIEF FINANCIAL OFFICER | ESCA Escalade, Incorporated | Sale | 2,000 | $13.00 | $26.0K Sale | Form 4 ↗ |
| Sep 15, 2025 | Richard Fenton Baalmann Jr. Director | ESCA Escalade, Incorporated | Sale | 4,800 | $12.29 | $59.0K Sale | Form 4 ↗ |
| May 16, 2025 | Stephen Wawrin CHIEF FINANCIAL OFFICER | ESCA Escalade, Incorporated | Sale | 2,177 | $15.16 | $33.0K Sale | Form 4 ↗ |
| Dec 9, 2024 | Stephen Wawrin CHIEF FINANCIAL OFFICER | ESCA Escalade, Incorporated | Sale | 1,809 | $15.75 | $28.5K Sale | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances